TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Yuyan Cheng(University of Miami), Eléonore Beurel(University of Miami), Ryan J. Worthen(University of Miami), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Sachi Desse(University of Miami), Richard S. Jope(University of Miami)
Cited by 293
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
|Neuropsychopharmacology|2004|300